As a pre-commercial biotech prepared for its first product launch and ISO 13485 certification, paper-based quality processes were becoming a risk to both speed and compliance. By moving to a validated digital QMS, the team created a more controlled, audit-ready foundation — improving traceability, streamlining approvals, and giving the company a scalable path to market readiness.
They solved the challenge by moving from binders and manual approvals to a unified digital system built for compliance and scale. That shift reduced document chaos, improved traceability, and gave the team a market-ready quality foundation before the first unit shipped.